Last Updated by Anonymous | Update This Page Flag this page Delete This Page

rating: 0+x

Biotechnology companies must spend lots of money to improve their pipelines. Biogen needs to improve their cost structure. … This qualitative factor will lead to an increase in costs. "Cost Structure at Biogen Hurts Profitability" is an easy qualitative factor to overcome, so the investment will not have to spend much time trying to overcome this issue.